The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Blockage of Tubular Epithelial to Myofibroblast Transition by Hepatocyte Growth Factor Prevents Renal Interstitial Fibrosis
Abstract
Activation of alpha-smooth muscle actin-positive myofibroblast cells is a key event in the progression of chronic renal diseases that leads to end-stage renal failure. Although the origin of these myofibroblasts in the kidney remains uncertain, emerging evidence suggests that renal myofibroblasts may derive from tubular epithelial cells by a process of epithelial to mesenchymal transition. It was demonstrated that hepatocyte growth factor (HGF) exhibited a remarkable ability to block this phenotypic transition both in vitro and in vivo. HGF abrogated the alpha-smooth muscle actin expression and E-cadherin depression triggered by transforming growth factor-beta1 in tubular epithelial cells in a dose-dependent manner. HGF also blocked morphologic transformation of tubular epithelial cells and inhibited the expression and extracellular deposition of fibronectin. In a mouse model of renal fibrosis disease induced by unilateral ureteral obstruction, transforming growth factor-beta type I receptor expression was specifically increased in renal tubules, and myofibroblastically phenotypic transition of the tubules was evident in vivo. Remarkably, injections of exogenous HGF blocked myofibroblast activation and drastically prevented renal interstitial fibrosis in the obstructed kidneys. These results suggest that tubular epithelial to myofibroblast conversion may play an important role in the pathogenesis of renal fibrosis and that blocking this phenotypic transition could provide a novel therapeutic strategy for the treatment of fibrotic diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cano, A., Pérez-Moreno, M. A., Rodrigo, I., Locascio, A., Blanco, M. J., del Barrio, M. G., Portillo, F., & Nieto, M. A. (2000) · Nature Cell Biology · doi:10.1038/35000025 · Cited by 3,668
Batlle, E., Sancho, E., Francí, C., Domínguez, D., Monfar, M., Baulida, J., & García de Herreros, A. (2000) · Nature Cell Biology · doi:10.1038/35000034 · Cited by 2,666
Pathophysiology of Progressive Nephropathies
Remuzzi, G., & Bertani, T. (1998) · New England Journal of Medicine · doi:10.1056/nejm199811123392007 · Cited by 1,269
Identification and characterization of a fibroblast marker: FSP1.
Strutz, F., Okada, H., Lo, C. W., Danoff, T., Carone, R. L., Tomaszewski, J. E., & Neilson, E. G. (1995) · The Journal of cell biology · doi:10.1083/jcb.130.2.393 · Cited by 1,077
Bar-Sagi, D., & Hall, A. (2000) · Cell · doi:10.1016/s0092-8674(00)00115-x · Cited by 779
Sonnenberg, E., Meyer, D., Weidner, K. M., & Birchmeier, C. (1993) · The Journal of cell biology · doi:10.1083/jcb.123.1.223 · Cited by 698
Molecular insights into renal interstitial fibrosis.
Eddy, A. A. (1996) · Journal of the American Society of Nephrology · doi:10.1681/asn.v7122495 · Cited by 637
A targeted mutation in the mouse E-cadherin gene results in defective preimplantation development.
Riethmacher, D., Brinkmann, V, & Birchmeier, C. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.3.855 · Cited by 505
Interactions of Transforming Growth Factor-β and Angiotensin II in Renal Fibrosis
Border, W. A., & Noble, N. A. (1998) · Hypertension · doi:10.1161/01.hyp.31.1.181 · Cited by 447
Early role of Fsp1 in epithelial-mesenchymal transformation
Okada, H., Danoff, T. M., Kalluri, R., & Neilson, E. G. (1997) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1997.273.4.f563 · Cited by 434
Cited by
The basics of epithelial-mesenchymal transition
Kalluri, R., & Weinberg, R. A. (2009) · Journal of Clinical Investigation · doi:10.1172/jci39104 · Cited by 10,196
Epithelial-mesenchymal transition and its implications for fibrosis
Kalluri, R., & Neilson, E. G. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200320530 · Cited by 2,649
Epithelial–mesenchymal transitions in development and pathologies
Thiery, J. P. (2003) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2003.10.006 · Cited by 1,704
Cellular and molecular mechanisms of renal fibrosis
Liu, Y. (2011) · Nature Reviews Nephrology · doi:10.1038/nrneph.2011.149 · Cited by 1,446
Self-citationRenal fibrosis: New insights into the pathogenesis and therapeutics
Liu, Y. (2006) · Kidney International · doi:10.1038/sj.ki.5000054 · Cited by 1,089
Self-citationLiu, Y. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000106015.29070.e7 · Cited by 1,055
Self-citationNew Insights into Epithelial-Mesenchymal Transition in Kidney Fibrosis
Liu, Y. (2010) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008121226 · Cited by 870
Self-citationMechanisms of Tubulointerstitial Fibrosis
Zeisberg, M., & Neilson, E. G. (2010) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010080793 · Cited by 868
Fibroblasts Derive from Hepatocytes in Liver Fibrosis via Epithelial to Mesenchymal Transition
Zeisberg, M., Yang, C., Martino, M., Duncan, M. B., Rieder, F., Tanjore, H., & Kalluri, R. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m700194200 · Cited by 839
Diverse cellular and molecular mechanisms contribute to epithelial plasticity and metastasis
Grünert, S., Jechlinger, M., & Beug, H. (2003) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1175 · Cited by 678
Obstructive nephropathy and renal fibrosis
Klahr, S., & Morrissey, J. (2002) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00362.2001 · Cited by 555
Wnt/β-Catenin Signaling Promotes Renal Interstitial Fibrosis
He, W., Dai, C., Li, Y., Zeng, G., Monga, S. P., & Liu, Y. (2009) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008060566 · Cited by 549
Self-citationNAKAMURA, T., & MIZUNO, S. (2010) · Proceedings of the Japan Academy, Series B · doi:10.2183/pjab.86.588 · Cited by 547
the Accelerating Medicines Partnership Rheumatoid Arthritis and Systemic Lupus Erythematosus (AMP RA/SLE) Consortium, Der, E., Suryawanshi, H., Morozov, P., Kustagi, M., Goilav, B., Ranabothu, S., Izmirly, P., Clancy, R., Belmont, H. M., et al. (2019) · Nature Immunology · doi:10.1038/s41590-019-0386-1 · Cited by 403
Hayashida, T., de Caestecker, M., & Schnaper, H. W. (2003) · The FASEB Journal · doi:10.1096/fj.03-0037fje · Cited by 361
Li, Y., Kang, Y. S., Dai, C., Kiss, L. P., Wen, X., & Liu, Y. (2008) · The American Journal of Pathology · doi:10.2353/ajpath.2008.070057 · Cited by 338
Self-citationLi, Y., Yang, J., Dai, C., Wu, C., & Liu, Y. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17913 · Cited by 337
Self-citationRenal Fibroblasts and Myofibroblasts in Chronic Kidney Disease
Strutz, F., & Zeisberg, M. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006050420 · Cited by 324
TGF-β signal transduction and mesangial cell fibrogenesis
Schnaper, H. W., Hayashida, T., Hubchak, S. C., & Poncelet, A.-C. (2003) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00300.2002 · Cited by 311
Li, Y., Yang, J., Dai, C., Wu, C., & Liu, Y. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200317913 · Cited by 303
Self-citationDiverse origins of the myofibroblast—implications for kidney fibrosis
Falke, L. L., Gholizadeh, S., Goldschmeding, R., Kok, R. J., & Nguyen, T. Q. (2015) · Nature Reviews Nephrology · doi:10.1038/nrneph.2014.246 · Cited by 299
The role of EMT in renal fibrosis
Carew, R. M., Wang, B., & Kantharidis, P. (2012) · Cell and Tissue Research · doi:10.1007/s00441-011-1227-1 · Cited by 294
Paricalcitol Attenuates Renal Interstitial Fibrosis in Obstructive Nephropathy
Tan, X., Li, Y., & Liu, Y. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006050520 · Cited by 280
Self-citationLiver fibrosis: cellular mechanisms of progression and resolution
Henderson, N. C., & Iredale, J. P. (2007) · Clinical Science · doi:10.1042/cs20060242 · Cited by 270
Glomerular endothelial cell injury and cross talk in diabetic kidney disease
Fu, J., Lee, K., Chuang, P. Y., Liu, Z., & He, J. C. (2015) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00533.2014 · Cited by 266
Hepatocyte growth factor in kidney fibrosis: therapeutic potential and mechanisms of action
Liu, Y. (2004) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00451.2003 · Cited by 265
Self-citationTubular epithelial-myofibroblast transdifferentiation mechanisms in proximal tubule cells
Lan, H. Y. (2003) · Current Opinion in Nephrology and Hypertension · doi:10.1097/00041552-200301000-00005 · Cited by 259
Epithelial-to-Mesenchymal Transition in Diabetic Nephropathy: Fact or Fiction?
Loeffler, I., & Wolf, G. (2015) · Cells · doi:10.3390/cells4040631 · Cited by 255
Giannopoulou, M., Dai, C., Tan, X., Wen, X., Michalopoulos, G. K., & Liu, Y. (2008) · The American Journal of Pathology · doi:10.2353/ajpath.2008.070583 · Cited by 126
Self-citationEpithelial-to-mesenchymal transition and chronic allograft tubulointerstitial fibrosis
Bedi, S., Vidyasagar, A., & Djamali, A. (2008) · Transplantation Reviews · doi:10.1016/j.trre.2007.09.004 · Cited by 100
20-Hydroxyecdysone Attenuates TGF-Β1-Induced Renal Cellular Fibrosis in Proximal Tubule Cells
Hung, T.-J., Chen, W.-M., Liu, S.-F., Liao, T.-N., Lee, T.-C., Chuang, L.-Y., Guh, J.-Y., Hung, C.-Y., Hung, Y.-J., Chen, P.-Y., et al. (2012) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2012.06.014 · Cited by 25
Glucosidase inhibitor, Nimbidiol ameliorates renal fibrosis and dysfunction in type-1 diabetes
Juin, S. K., Pushpakumar, S., Tyagi, S. C., & Sen, U. (2022) · Scientific Reports · doi:10.1038/s41598-022-25848-1 · Cited by 18
Metadata
- Authors
- Yang, J., & Liu, Y.
- Venue
- Journal of the American Society of Nephrology
- Published
- 2002-01
- Volume
- 13
- Issue
- 1
- Pages
- 96-107
- ISSN
- 1046-6673 (ISSN-L)
- OpenAlex
- W2168918540
- Cited by
- 326
- References
- 36
- FWCI
- 17.45
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.